炎症酶蛋白质支架在瘤发育期间造成DNA损伤的复杂
Cheng Shen1, Abhimanu Pandey1, Daniel Enosi Tuipulotu1
1Division of Immunology and Infectious Diseases, The John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.
Nature immunology
|October 14, 2024
概括
炎症蛋白NLRC4 (NLR家族CARD域含蛋白4) 通过激活DNA损伤反应通路来抑制瘤的发展,独立于其炎症作用. 这一发现揭示了NLRC4.4的新型癌症保护功能.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 炎症酶体是关键的信号平台,参与炎症和细胞死亡.
- 一些炎症酶表现出超出规范炎症通路的功能.
- 目前尚不完全了解NLRC4在瘤发育中的作用.
研究的目的:
- 研究NLRC4在瘤发育中的作用.
- 阐明NLRC4影响瘤抑制的分子机制.
- 为了确定NLRC4的瘤抑制功能是否与炎症体信号传递有关.
主要方法:
- 利用Apcmin/+小鼠模型进行瘤发育研究.
- 研究了涉及NLRC4,ATR,ATRIP和ETAA1.1的蛋白质与蛋白质相互作用.
- 评估基因毒性后的DNA损伤反应途径,包括CHK1激活.
主要成果:
- 在Apcmin/+小鼠模型中NLRC4减弱了瘤的发展.
- 这种瘤抑制独立于已知的炎症体信号组件.
- NLRC4与ATR-ATRIP-ETAA1复合体直接相互作用,促进CHK1激活和DNA损伤反应.
结论:
- 在促进DNA损伤反应方面,NLRC4具有非正规的非炎症功能.
- 通过增强DNA修复机制,NLRC4充当瘤抑制剂.
- 这些发现突出了炎症蛋白在癌症保护中的新作用.
更多相关视频
相关概念视频
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
DNA Damage Can Stall the Cell Cycle
2.6K
2.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


